DMF BID and TID produced significant and consistent reductions vs placebo in the number of new or enlarging T@-hyperintense lesions and new nonenhancing T@-hypointense lesions after @ and @ years of treatment and in the number of Gd + lesions at week @ , year @ , and year @ .